Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Anti-TNF in Biologic-Naive Rheumatoid Arthritis
NCT01021735Phase 4Completed
- Sponsor
- University of Glasgow
- Start
- Apr 2010
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in rheumatoid arthritis (RA), sponsored by University of Glasgow. Started Apr 2010; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01021735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01021735.